Caxton Associates (New York)’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,486	Closed	-$432K	–	521
2021 Q4	$432K	Buy	+9,486	New	+$432K	0.04%	293
2020 Q2	–	Sell	-13,175	Closed	-$155K	–	480
2020 Q1	$155K	Buy	+13,175	New	+$155K	0.03%	363